20050413
 Barr Pharmaceuticals Inc.: Kos's Cholesterol Drugs to Get Co-Promoted to Settle Dispute   The Wall Street Journal,  Apr 14, 2005  Barr Pharmaceuticals Inc. agreed to co-promote Kos Pharmaceuticals Inc.'s cholesterol-reduction drugs and signed a licensing pact, settling a patent dispute between the drug makers. As part of the agreement, Barr, a generic-drug maker based in Woodcliff Lake, N.J., admitted it infringed Kos's patents.   
